# HemaTrate™ in the Treatment of Critical Limb Ischemia

> **NCT03809494** · NA · TERMINATED · sponsor: **Cook Research Incorporated** · enrollment: 2 (actual)

## Conditions studied

- Critical Limb Ischemia
- Ischemia

## Interventions

- **DEVICE:** HemaTrate™ Blood Filtration system
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT03809494
- **Lead sponsor:** Cook Research Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-23
- **Primary completion:** 2020-11-27
- **Final completion:** 2020-11-27
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study has stopped early due to enrollment challenges related largely to the current pandemic
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809494, "HemaTrate™ in the Treatment of Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03809494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*